The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
Open accessAbstract
Sirtuins are a highly conserved class of NAD+-dependent lysine deacylases. The human isotype Sirt2 has been implicated in the pathogenesis of cancer, inflammation and neurodegeneration, which makes the modulation of Sirt2 activity a promising strategy for pharmaceutical intervention. A rational basis for the development of optimized Sirt2 inhibitors is lacking so far. Here we present high-resolution structures of human Sirt2 in complex with highly selective drug-like inhibitors that show a unique inhibitory mechanism. Potency and the unprecedented Sirt2 selectivity are based on a ligand-induced structural rearrangement of the active site unveiling a yet-unexploited binding pocket. Application of the most potent Sirtuin-rearranging ligand, termed SirReal2, leads to tubulin hyperacetylation in HeLa cells and induces destabilization of the checkpoint protein BubR1, consistent with Sirt2 inhibition in vivo. Our structural insights into this unique mechanism of selective sirtuin inhibition provide the basis for further inhibitor development and selective tools for sirtuin biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
REFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,317
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
Laskowski, R. A., & Swindells, M. B. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200227u · Cited by 6,471
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697
Molecular replacement with MOLREP
Vagin, A., & Teplyakov, A. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042589 · Cited by 3,604
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Niesen, F. H., Berglund, H., & Vedadi, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.321 · Cited by 2,408
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · cited 1×
“These changes are not as pronounced when compared with the changes induced by the inhibition of the other main tubulin deacetylase KDAC6 (refs 38,39).”
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Linking Crystallographic Model and Data Quality
Karplus, P. A., & Diederichs, K. (2012) · Science · doi:10.1126/science.1218231 · Cited by 1,781
The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., & Verdin, E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00038-8 · Cited by 1,536
Self-citationSirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., et al. (2011) · Science · doi:10.1126/science.1207861 · Cited by 1,429
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation
Lombard, D. B., Alt, F. W., Cheng, H.-L., Bunkenborg, J., Streeper, R. S., Mostoslavsky, R., Kim, J., Yancopoulos, G., Valenzuela, D., Murphy, A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01636-07 · Cited by 1,216
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204
Di Tommaso, P., Moretti, S., Xenarios, I., Orobitg, M., Montanyola, A., Chang, J.-M., Taly, J.-F., & Notredame, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr245 · Cited by 1,165
Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease
Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J.-C., McLean, P. J., et al. (2007) · Science · doi:10.1126/science.1143780 · Cited by 1,062
SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine
Jiang, H., Khan, S., Wang, Y., Charron, G., He, B., Sebastian, C., Du, J., Kim, R., Ge, E., Mostoslavsky, R., et al. (2013) · Nature · doi:10.1038/nature12038 · Cited by 697
Feldman, J. L., Baeza, J., & Denu, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.511261 · Cited by 637 · cited 2×
“(a) Chemical structure of SirReal2 (1).”
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Kim, H.-S., Vassilopoulos, A., Wang, R.-H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T. D., Li, B., Yu, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.004 · Cited by 537
Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1
Napper, A. D., Hixon, J., McDonagh, T., Keavey, K., Pons, J.-F., Barker, J., Yau, W. T., Amouzegh, P., Flegg, A., Hamelin, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050522v · Cited by 523
Avalos, J. L., Bever, K. M., & Wolberger, C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.022 · Cited by 464
HOLLOW: Generating Accurate Representations of Channel and Interior Surfaces in Molecular Structures
Ho, B. K., & Gruswitz, F. (2008) · BMC Structural Biology · doi:10.1186/1472-6807-8-49 · Cited by 446
Laurent, G., German, N. J., Saha, A. K., de Boer, V. C. J., Davies, M., Koves, T. R., Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.012 · Cited by 391
Self-citationStructure of the histone deacetylase SIRT2.
Finnin, M. S., Donigian, J. R., & Pavletich, N. P. (2001) · Nature Structural Biology · doi:10.1038/89668 · Cited by 385
Ex-527 inhibits Sirtuins by exploiting their unique NAD + -dependent deacetylation mechanism
Gertz, M., Fischer, F., Nguyen, G. T. T., Lakshminarasimhan, M., Schutkowski, M., Weyand, M., & Steegborn, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303628110 · Cited by 317
Self-citationStructure and Biochemical Functions of SIRT6
Pan, P. W., Feldman, J. L., Devries, M. K., Dong, A., Edwards, A. M., & Denu, J. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.218990 · Cited by 310
NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs
Vaquero, A., Sternglanz, R., & Reinberg, D. (2007) · Oncogene · doi:10.1038/sj.onc.1210617 · Cited by 296
Serrano, L., Martínez-Redondo, P., Marazuela-Duque, A., Vazquez, B. N., Dooley, S. J., Voigt, P., Beck, D. B., Kane-Goldsmith, N., Tong, Q., Rabanal, R. M., et al. (2013) · Genes & Development · doi:10.1101/gad.211342.112 · Cited by 281
A Role for SIRT2-Dependent Histone H3K18 Deacetylation in Bacterial Infection
Eskandarian, H. A., Impens, F., Nahori, M.-A., Soubigou, G., Coppée, J.-Y., Cossart, P., & Hamon, M. A. (2013) · Science · doi:10.1126/science.1238858 · Cited by 267
Structural Basis of Inhibition of the Human NAD+-Dependent Deacetylase SIRT5 by Suramin
Schuetz, A., Min, J., Antoshenko, T., Wang, C.-L., Allali-Hassani, A., Dong, A., Loppnau, P., Vedadi, M., Bochkarev, A., Sternglanz, R., et al. (2007) · Structure · doi:10.1016/j.str.2007.02.002 · Cited by 261
Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan
Baker, D. J., Dawlaty, M. M., Wijshake, T., Jeganathan, K. B., Malureanu, L., van Ree, J. H., Crespo-Diaz, R., Reyes, S., Seaburg, L., Shapiro, V., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2643 · Cited by 246
SIRT2 induces the checkpoint kinase BubR1 to increase lifespan
North, B. J., Rosenberg, M. A., Jeganathan, K. B., Hafner, A. V., Michan, S., Dai, J., Baker, D. J., Cen, Y., Wu, L. E., Sauve, A. A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201386907 · Cited by 238
Self-citationStructure of a Sir2 Enzyme Bound to an Acetylated p53 Peptide
Avalos, J. L., Celic, I., Muhammad, S., Cosgrove, M. S., Boeke, J. D., & Wolberger, C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00628-7 · Cited by 237
Zhao, X., Allison, D., Condon, B., Zhang, F., Gheyi, T., Zhang, A., Ashok, S., Russell, M., MacEwan, I., Qian, Y., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301431y · Cited by 223
The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models
Chopra, V., Quinti, L., Kim, J., Vollor, L., Narayanan, K. L., Edgerly, C., Cipicchio, P. M., Lauver, M. A., Choi, S. H., Silverman, R. B., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.11.001 · Cited by 212
The histone deacetylase SIRT2 stabilizes Myc oncoproteins
Liu, P. Y., Xu, N., Malyukova, A., Scarlett, C. J., Sun, Y. T., Zhang, X. D., Ling, D., Su, S.-P., Nelson, C., Chang, D. K., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.147 · Cited by 207
Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes
Jin, L., Wei, W., Jiang, Y., Peng, H., Cai, J., Mao, C., Dai, H., Choy, W., Bemis, J. E., Jirousek, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014928 · Cited by 204
Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3
Disch, J. S., Evindar, G., Chiu, C. H., Blum, C. A., Dai, H., Jin, L., Schuman, E., Lind, K. E., Belyanskaya, S. L., Deng, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400204k · Cited by 194
Structural and Functional Analysis of Human SIRT1
Davenport, A. M., Huber, F. M., & Hoelz, A. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.009 · Cited by 179
Pais, T. F., Szegő, É. M., Marques, O., Miller‐Fleming, L., Antas, P., Guerreiro, P., de Oliveira, R. M., Kasapoglu, B., & Outeiro, T. F. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.200 · Cited by 175
Beirowski, B., Gustin, J., Armour, S. M., Yamamoto, H., Viader, A., North, B. J., Michán, S., Baloh, R. H., Golden, J. P., Schmidt, R. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104969108 · Cited by 174
Self-citationEnhanced fold recognition using efficient short fragment clustering.
Krissinel, E. (2012) · PubMed · Cited by 172
Investigating the ADP-ribosyltransferase Activity of Sirtuins with NAD Analogues and 32P-NAD
Du, J., Jiang, H., & Lin, H. (2009) · Biochemistry · doi:10.1021/bi802093g · Cited by 165
Trapp, J., Jochum, A., Meier, R., Saunders, L. R., Marshall, B. L., Kunick, C., Verdin, E. M., Goekjian, P. G., Sippl, W., & Jung, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060118b · Cited by 153
Self-citationHoffmann, G., Breitenbücher, F., Schüler, M., & Ehrenhofer‐Murray, A. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.487736 · Cited by 144
HDAC6 and SIRT2 Regulate the Acetylation State and Oncogenic Activity of Mutant K-RAS
Yang, M. H., Laurent, G., Bause, A. S., Spang, R., German, N. J., Haigis, M. C., & Haigis, K. M. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0040-t · Cited by 144
SIRT2 as a Therapeutic Target for Age-Related Disorders
de Oliveira, R. M., Sarkander, J., Kazantsev, A. G., & Outeiro, T. F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00082 · Cited by 143
Insights into the Sirtuin Mechanism from Ternary Complexes Containing NAD+ and Acetylated Peptide
Hoff, K. G., Avalos, J. L., Sens, K. L., & Wolberger, C. (2006) · Structure · doi:10.1016/j.str.2006.06.006 · Cited by 141
Bobrowska, A., Dönmez, G., Weiss, A., Guarente, L., & Bates, G. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034805 · Cited by 131
Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors
Suzuki, T., Khan, M. N. A., Sawada, H., Imai, E., Itoh, Y., Yamatsuta, K., Tokuda, N., Takeuchi, J., Seko, T., Nakagawa, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3002108 · Cited by 130
Crystal structure analysis of human Sirt2 and its ADP-ribose complex
Moniot, S., Schutkowski, M., & Steegborn, C. (2013) · Journal of Structural Biology · doi:10.1016/j.jsb.2013.02.012 · Cited by 121
Self-citationIn vitro assays for the determination of histone deacetylase activity
Heltweg, B., Trapp, J., & Jung, M. (2005) · Methods · doi:10.1016/j.ymeth.2005.03.003 · Cited by 116
Self-citationTPPP/p25 Promotes Tubulin Acetylation by Inhibiting Histone Deacetylase 6
Tőkési, N., Lehotzky, A., Horváth, I., Szabó, B., Oláh, J., Lau, P., & Ovádi, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.096578 · Cited by 108
Self-citationYamagata, K., Goto, Y., Nishimasu, H., Morimoto, J., Ishitani, R., Dohmae, N., Takeda, N., Nagai, R., Komuro, I., Suga, H., et al. (2014) · Structure · doi:10.1016/j.str.2013.12.001 · Cited by 99
The Structural Basis of Sirtuin Substrate Affinity,
Cosgrove, M. S., Bever, K. M., Avalos, J. L., Muhammad, S., Zhang, X., & Wolberger, C. (2006) · Biochemistry · doi:10.1021/bi0526332 · Cited by 93
Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach
Cui, H., Kamal, Z., Ai, T., Xü, Y., More, S. S., Wilson, D. J., & Chen, L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500777s · Cited by 86
Synthesis of Carba-NAD and the Structures of Its Ternary Complexes with SIRT3 and SIRT5
Szczepankiewicz, B. G., Dai, H., Koppetsch, K. J., Qian, D., Jiang, F., Mao, C., & Perni, R. B. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo301067e · Cited by 77
Nguyen, G. T. T., Gertz, M., & Steegborn, C. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.019 · Cited by 77
Self-citationStructure-based development of novel sirtuin inhibitors
Schlicker, C., Boanca, G., Lakshminarasimhan, M., & Steegborn, C. (2011) · Aging · doi:10.18632/aging.100388 · Cited by 74
Self-citationInhibitors of the NAD+-Dependent Protein Desuccinylase and Demalonylase Sirt5
Maurer, B., Rumpf, T., Scharfe, M., Stolfa, D. A., Schmitt, M., He, W., Verdin, E. M., Sippl, W., & Jung, M. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3002709 · Cited by 71
Self-citationNguyen, G. T. T., Schaefer, S., Gertz, M., Weyand, M., & Steegborn, C. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913015448 · Cited by 68
Self-citationTubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors
Sanjuan, V. M., Oláh, J., González‐Álvarez, I., Lehotzky, A., Tőkési, N., Bermejo, M., & Ovádi, J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12946 · Cited by 18
Self-citation
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
Salo-Ahen, O. M. H., Alanko, I., Bhadane, R., Bonvin, A. M. J. J., Honorato, R. V., Hossain, S., Juffer, A. H., Kabedev, A., Lahtela-Kakkonen, M., Larsen, A. S., et al. (2020) · Processes · doi:10.3390/pr9010071 · Cited by 659
Targeted protein degradation: elements of PROTAC design
Paiva, S.-L., & Crews, C. M. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.02.022 · Cited by 576
Sirtuin activators and inhibitors: Promises, achievements, and challenges
Dai, H., Sinclair, D. A., Ellis, J. L., & Steegborn, C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.004 · Cited by 463
“The SIRT2 acyl channel and extension can undergo conformational changes that contribute to potent and SIRT2 selective inhibition by SirReal2 (Table 1) and thienopyrimidinones (Table 1; Figure 3b) (Rumpf et al., 2015; Sundriyal et al., 2017), and the SIRT2 specific pocket and its dynamics might explain why this isoform…”
Self-citationSirtuin functions and modulation: from chemistry to the clinic
Carafa, V., Rotili, D., Forgione, M., Cuomo, F., Serretiello, E., Hailu, G. S., Jarho, E., Lahtela-Kakkonen, M., Mai, A., & Altucci, L. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0224-3 · Cited by 387
Metadata
- Authors
- Rumpf, T., Schiedel, M., Karaman, B., Roessler, C., North, B. J., Lehotzky, A., Oláh, J., Ladwein, K. I., Schmidtkunz, K., Gajer, M., Pannek, M., Steegborn, C., Sinclair, D. A., Gerhardt, S., Ovádi, J., Schutkowski, M., Sippl, W., Einsle, O., & Jung, M.
- Venue
- Nature Communications
- Published
- 2015-02-12
- Volume
- 6
- Issue
- 1
- Pages
- 6263-6263
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2120608933
- Cited by
- 297
- References
- 69
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.